A study to estimate the effect of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects.

Trial Profile

A study to estimate the effect of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Feb 2009

At a glance

  • Drugs Nelfinavir (Primary) ; Omeprazole
  • Indications Gastrointestinal disorders; HIV infections
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 13 Feb 2009 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
    • 13 Feb 2009 Additional lead trial centres identified as reported by ClinicalTrials.gov, last updated 13-Feb-2009.
    • 28 Aug 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top